Home > R&D > Research Progress

Research Progress

Our scientists focus on the discovery and development of animal-free products for industrial and pharmaceutical use:

recombinant human serum albumin (rHSA), recombinant alpha-1 antitrypsin (rAAT), recombinant acidic fibroblast
growth factor (raFGF) and recombinant basic fibroblast growth factor (rbFGF).

Our study shows these plant-derived products are structurally and biochemically equivalent to or higher than those
in native form.

 

Innovation is the driving force behind Healthgen’s future growth supported by a strong Research & Development 
(R&D) Pipeline.

 

Healthgen’s current pipeline programs comprise:

 

human serum albumin

human albumin

recombinant albumin

rHSA

recombinant HSA

recombinant HSA | Human serum albumin | Terms & Conditions          Copyright © Healthgen Biotechnology Co., Ltd. All Rights Reserved.